新医学2024,Vol.55Issue(2) :87-91.DOI:10.3969/j.issn.0253-9802.2024.02.002

视神经萎缩蛋白1与糖尿病心肌病相关性的研究进展

Research progress on the association between Opa1 and diabetic cardiomyopathy

李向庚 高媛 孙淑艳
新医学2024,Vol.55Issue(2) :87-91.DOI:10.3969/j.issn.0253-9802.2024.02.002

视神经萎缩蛋白1与糖尿病心肌病相关性的研究进展

Research progress on the association between Opa1 and diabetic cardiomyopathy

李向庚 1高媛 2孙淑艳2
扫码查看

作者信息

  • 1. 014000 包头,内蒙古科技大学包头医学院研究生院
  • 2. 014010 包头,内蒙古科技大学包头医学院第一附属医院
  • 折叠

摘要

糖尿病心肌病(DCM)是指单纯由高血糖引起的心肌细胞或心脏微血管损伤及代谢障碍.有研究表明,DCM与线粒体融合异常密切相关.视神经萎缩蛋白 1(Opa1)是线粒体融合的主要蛋白之一.在高血糖环境下,Opa1表达减少,造成线粒体融合障碍,进而引起心肌细胞能量代谢障碍、氧化应激、胰岛素抵抗与脂毒性增加、细胞凋亡等,最终导致DCM.上调Opa1 的表达则能使DCM的症状得到改善.该文就Opa1 与DCM的相关性的研究进展做一综述,为DCM的研究提供新思路.

Abstract

Diabetic cardiomyopathy(DCM)refers to myocardial cell or cardiac microvascular injury and metabolic disorder caused by hyperglycemia alone.Studies have shown that DCM is closely associated with abnormal mitochondrial fusion.Optic atrophy 1(Opa1)is one of the main proteins of mitochondrial fusion.Under hyperglycemia environment,the expression level of Opa1-1 is down-regulated,resulting in mitochondrial fusion disorder,which thereby leads to energy metabolism disorder,oxidative stress,increased insulin resistance,lipotoxicity and apoptosis,and finally causes DCM.Up-regulating the expression level of Opa1 can mitigate the symptoms of DCM.In this article,research progress in the correlation between Opa1 and DCM was reviewed,aiming to provide novel ideas for DCM research.

关键词

视神经萎缩蛋白1/线粒体融合/糖尿病心肌病/心肌细胞/发病机制/能量代谢障碍/氧化应激/胰岛素抵抗与脂毒性/细胞凋亡

Key words

Optic atrophy 1/Mitochondrial fusion/Diabetic cardiomyopathy/Cardiomyocyte/Pathogenesis/Energy metabolism disorder/Oxidative stress/Insulin resistance and lipotoxicity/Apoptosis

引用本文复制引用

基金项目

内蒙古自治区自然科学基金(2021LHMS08008)

出版年

2024
新医学
中山大学

新医学

CSTPCD
影响因子:0.8
ISSN:0253-9802
参考文献量36
段落导航相关论文